Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 , Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Using Premedication With OsrhCT and Dimethicone Emulsion During Upper Gastrointestinal Endoscopy Examination.

NCT06722664 is registered in ClinicalTrials.gov with Healthgen Biotechnology Corp. as lead sponsor.

NCT NCT06722664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06722664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 , Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Using Premedication With OsrhCT and Dimethicone Emulsion During Upper Gastrointestinal Endoscopy Examination.
Lead sponsor
Healthgen Biotechnology Corp.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 19, 2024
Completion date
May 15, 2025
Enrollment
336 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

gastric mucosal lesion